BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 399869)

  • 1. The ability of syngeneic spleen cells coated with antilymphocyte antibodies in vitro to prolong the skin allograft survival in mice.
    Rudnicka W
    Bull Acad Pol Sci Biol; 1979; 27(12):1015-20. PubMed ID: 399869
    [No Abstract]   [Full Text] [Related]  

  • 2. The ability of ALS against lymph node lymphocyte subpopulations to prolong the skin allograft survival in mice.
    Rudnicka W; GoĊ›cicka T; Szewczyk K; Zelazowski P; Zablocki B
    Bull Acad Pol Sci Biol; 1976; 24(1):27-31. PubMed ID: 766923
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of posttransplant-administered peripheral blood lymphocytes for prolonging allograft survival in ALS-treated mice.
    Gozzo JJ; Monaco AP; De Fazio SR
    Transplant Proc; 1989 Feb; 21(1 Pt 1):269-70. PubMed ID: 2650116
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolongation of the survival of skin allografts by the injection of spleen cells in adult mice treated by antilymphocyte serum.
    Brochier J; Fries D
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):303-7. PubMed ID: 4559763
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of posttransplant injection of peripheral blood lymphocytes on skin graft prolongation in mice treated with antilymphocyte serum (ALS) or ALS plus donor bone marrow.
    Gozzo JJ; Hartner WC; Monaco AP; De Fazio SR
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1409-10. PubMed ID: 3274341
    [No Abstract]   [Full Text] [Related]  

  • 6. Tolerance induction to skin allografts following intrathymic injection with donor-specific splenocytes in major histocompatibility complex class I, class I+MLS, and class I+II disparities.
    Ohzato H; Monaco AP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):297-8. PubMed ID: 8438307
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of antilymphocyte serum on the redifferentiation of hematopoietic stem cells by syngeneic lymphocytes].
    Golovistikov IN; Bliakher MS; Zykov IuV
    Dokl Akad Nauk SSSR; 1972 Jun; 204(4):980-2. PubMed ID: 4557586
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
    Gozzo JJ; Wood ML; Pompei R; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antilymphocyte serum: methods for its preparation and measurement in vitro of its biological activity].
    Tursi A
    Haematologica; 1970 Dec; 55(12):766-73. PubMed ID: 5003116
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of heterologous antilymphocyte serum on the formation of H-2 antibody and the induction of allograft immunity.
    Monaco AP; Franco DJ
    Transplant Proc; 1969 Mar; 1(1):474-8. PubMed ID: 4944263
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of antilymphocyte serum on the thymus.
    Levey RH; Taub R
    Transplant Proc; 1969 Mar; 1(1):424-8. PubMed ID: 4944253
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of tolerance with antilymphocytic serum.
    Lance EM; Medawar PB
    Transplant Proc; 1969 Mar; 1(1):429-32. PubMed ID: 4944254
    [No Abstract]   [Full Text] [Related]  

  • 13. A new in vitro test evaluating anti-lymphocyte serum potency.
    Bach JF; Dardenne M; Dormont J; Antoine B
    Transplant Proc; 1969 Mar; 1(1):403-7. PubMed ID: 4944250
    [No Abstract]   [Full Text] [Related]  

  • 14. Specificity requirement of donor bone marrow cells that prolong allograft survival: implications for a veto cell mechanism of action.
    De Fazio SR; Markees TG; Hartner WC; Gozzo JJ
    Transplant Proc; 1995 Feb; 27(1):171-3. PubMed ID: 7878960
    [No Abstract]   [Full Text] [Related]  

  • 15. Adoptive transfer of specific unresponsiveness to skin allografts by spleen cells from ALS-treated, marrow-injected mice.
    Wood ML; Monaco AP
    Transplant Proc; 1979 Mar; 11(1):1023-7. PubMed ID: 377604
    [No Abstract]   [Full Text] [Related]  

  • 16. Synergy between injection of F1 spleen cells and thymectomy on maintenance of skin allograft tolerance in adult recipient mice treated with supralethal irradiation followed by syngeneic bone marrow cell transplantation.
    Tomita Y; Mayumi H; Nomoto K
    Transplant Proc; 1990 Feb; 22(1):251-6. PubMed ID: 2137950
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of antilymphocyte serum on the antigen-binding cells of the blood and the survival of skin grafts].
    Dinoeva S
    Eksp Med Morfol; 1976; 15(2):89-95. PubMed ID: 776589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro quantitative determination of the cellular response to skin allografts in mice].
    Degiovanni G
    C R Seances Soc Biol Fil; 1972; 166(4):722-7. PubMed ID: 4568591
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple nonspecific blood transfusions prolong skin allograft survival in immunosuppressed mice.
    Okazaki H; Maki T; Monaco AP
    Proc Clin Dial Transplant Forum; 1979; 9():230-3. PubMed ID: 399513
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphocyte environment and the durability of transplantation tolerance.
    Levey RH
    Transplant Proc; 1972 Sep; 4(3):395-9. PubMed ID: 4404152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.